|
2025 Conference Publication Updated results from the frailty-stratified, randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant ineligible myeloma (TI NDMM) – the FRAIL-m study (AMaRC 19-01; ALLG MM22)Lim, Sueh-Li, Reynolds, John, Pemberton, Lucy, Wright, Tricia, Lee, Sophie, Mollee, Peter, Shetty, Anita C., Kim, Yu Jin, Helen, Weston, Nina, Byard, Le, Khoa, McQuilten, Zoe, Quach, Hang and Spencer, Andrew (2025). Updated results from the frailty-stratified, randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant ineligible myeloma (TI NDMM) – the FRAIL-m study (AMaRC 19-01; ALLG MM22). 67th ASH Annual Meeting, Orlando, FL United States, 6-9 December 2025. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2025-5842 |
|
2025 Conference Publication Phase 1/2 dose escalation and expansion study of etentamig in patients with relapsed or refractory light chain amyloidosisChakraborty, Rajshekhar, Kastritis, Efstathios, Huart, Antoine, Jaccard, Arnaud, Landau, Heather, Iida, Shinsuke, Motorna, Olga, Mollee, Peter, Ishida, Tadao, Kawano, Yawara, Bhutani, Manisha, D'Souza, Anita, Cowan, Andrew, Hoffman, James, Talati, Chetasi, Rosenberg, Tanya, La Motte-Mohs, Ross, Wang, Fan, Hoffman, David, Fei, Mingwei, Arriola, Emma, Yu, Jovian, Kumar, Shaji, Dispenzieri, Angela, Palladini, Giovanni and Sanchorawala, Vaishali (2025). Phase 1/2 dose escalation and expansion study of etentamig in patients with relapsed or refractory light chain amyloidosis. 67th ASH Annual Meeting, Orlando, FL United States, 6-9 December 2025. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2025-692 |
|
2025 Conference Publication Primary analysis of the phase 3 randomized trial of selinexor and lenalidomide versus lenalidomide alone as maintenance therapy post autologous stem cell transplant for patients with newly diagnosed multiple myeloma (ALLG MM23; SEALAND)Rees, Matthew, Lasica, Masa, Kalff, Anna, Low, Michael, Harrup, Rosemary, Lai, Hock Choong, Sidiqi, M Hasib, Wong Doo, Nicole, Routledge, David, Hocking, Jay, Campbell, Philip, Heenan, Jessica, Horvath, Noemi, Chien, Nicole, Renwick, William, McCaughan, Georgia, Eek, Richard, Lenton, Douglas, Gazdar, Sher Gul, Mazumdar, Deepmala, Butcher, Belinda, Mollee, Peter and Quach, Hang (2025). Primary analysis of the phase 3 randomized trial of selinexor and lenalidomide versus lenalidomide alone as maintenance therapy post autologous stem cell transplant for patients with newly diagnosed multiple myeloma (ALLG MM23; SEALAND). 67th ASH Annual Meeting, Orlando, FL United States, 6-9 December 2025. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2025-4039 |
|
2025 Conference Publication Cytogenetic testing in newly diagnosed multiple myeloma (NDMM): Real world evidence of adverse outcomes for high risk groupsZammar, Ghassan, Augustson, Bradley, Moore, Elizabeth, Sidiqi, M Hasib, Wellard, Cameron, Ashrafi, Elham, Harrison, Simon, Radeski, Dejan, Jackson, Alannah, Bergin, Krystal, Ho, Phoebe Joy, King, Tracy, Mollee, Peter, Quach, Hang, Rajagopal, Rajeev, McQuilten, Zoe, Wood, Erica, Rosengarten, Brian and Spencer, Andrew (2025). Cytogenetic testing in newly diagnosed multiple myeloma (NDMM): Real world evidence of adverse outcomes for high risk groups. 67th ASH Annual Meeting, Orlando, FL United States, 6-9 December 2025. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2025-2221 |
|
2025 Conference Publication A Randomized Controlled Trial of Bone-Targeted Exercise for People with Multiple Myeloma: The MyeEx-Impact StudyNicol, Jennifer, King, Tracy, Chong, Jamie, Cunningham, Brent, Hart, Nicolas, Kay, Shelley, Woodrow, Carmel, Beck, Belinda, McDonald, Michelle, Carter, Daniel, Beer, Hayley, Boytar, Alex, Baguley, Brenton, Farley, Morgan, Rose, Grace, Mollee, Peter and Skinner, Tina (2025). A Randomized Controlled Trial of Bone-Targeted Exercise for People with Multiple Myeloma: The MyeEx-Impact Study. International Myeloma Society 22nd Annual Meeting and Exposition, Toronto, Canada, 17-20 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)03992-8 |
|
2025 Conference Publication Early Venetoclax Salvage in Systemic Light Chain Amyloidosis: A Retrospective Case SeriesMcVilly, Nicholas, Mollee, Peter, Anderson, Nirija Ranjit, Rowland, James, Korczyk, Dariusz, Sheikh, Nabeel and Abro, Emad (2025). Early Venetoclax Salvage in Systemic Light Chain Amyloidosis: A Retrospective Case Series. International Myeloma Society 22nd Annual Meeting and Exposition, Toronto, Canada, 17-20 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)03824-8 |
|
2025 Conference Publication Outcomes of Patients with Multiple Myeloma Post-BCMA Directed Treatment: An Australian PerspectiveLing, Jessica, Moore, Elizabeth, Wellard, Cameron, Spencer, Andrew, Ho, P. Joy, Mollee, Peter, Harrison, Simon, Augustson, Bradley, Quach, Hang and Sidiqi, M. Hasib (2025). Outcomes of Patients with Multiple Myeloma Post-BCMA Directed Treatment: An Australian Perspective. International Myeloma Society 22nd Annual Meeting and Exposition, Toronto, Canada, 17-20 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)03520-7 |
|
2025 Conference Publication Identification of Extracardiac Organ Involvement in Systemic Light Chain Amyloidosis using 18F-Florbetaben Positron Emission TomographyAnderson, Nirija Ranjit, Law, Phillip, Harrop, Danielle, Ng, Arnold, Wang, William, Korczyk, Dariusz and Mollee, Peter (2025). Identification of Extracardiac Organ Involvement in Systemic Light Chain Amyloidosis using 18F-Florbetaben Positron Emission Tomography. International Myeloma Society 22nd Annual Meeting and Exposition, Toronto, Canada, 17-20 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)03616-x |
|
2025 Conference Publication Amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometryMollee, Peter (2025). Amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry. Pathology Update 2025, Melbourne, VIC Australia, 21-23 February 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2024.12.033 |
|
2024 Conference Publication Efficacy and Safety of Isatuximab, Pomalidomide and Dexamethasone in Relapsed AL Amyloidosis: Interim Results of the Isamyp Phase 2 Joint Study from the IFM and ALLGMollee, Peter, Huart, Antoine, Mortona, Olga, Queru, Kentin, Leyronnas, Cecile, Stephanie, Harel, Sidiqi, Hasib, Desport, Estelle, Vincent, Laure, Macro, Margaret, Manier, Salomon, Jacquet, Caroline, Morel, Pierre, Horvath, Noemi, Bender, Sebastien, Olombel, Guillaume, Pascal, Virginie, Corre, Jill, Bridoux, Frank, Jaccard, Arnaud and Roussel, Murielle (2024). Efficacy and Safety of Isatuximab, Pomalidomide and Dexamethasone in Relapsed AL Amyloidosis: Interim Results of the Isamyp Phase 2 Joint Study from the IFM and ALLG. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-204700 |
|
2024 Conference Publication Treatment of First Relapse of Multiple Myeloma in Australia and New Zealand (ANZ): Treatment Patterns and Outcomes: An ANZ Myeloma and Related Diseases Registry (ANZ MRDR) AnalysisGration, Betty, Wellard, Cameron, Moore, Elizabeth, Tan, Marianne, Murphy, Matthew, Lim, Kenneth J. C., Rowland, James, Hamad, Nada, Rajagopal, Rajeev, Mollee, Peter, Spencer, Andrew, Quach, Hang and McCaughan, Georgia (2024). Treatment of First Relapse of Multiple Myeloma in Australia and New Zealand (ANZ): Treatment Patterns and Outcomes: An ANZ Myeloma and Related Diseases Registry (ANZ MRDR) Analysis. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-201790 |
|
2024 Conference Publication Integrating Chromosomal 1 Abnormalities into the Definition of High-Risk Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases RegistryLim, Kenneth J. C., Wellard, Cameron, Moore, Elizabeth, Gration, Betty, Augustson, Bradley, Mollee, Peter, Zhang, Jennifer, Wong Doo, Nicole, Ringkowski, Sabine, Bryant, Adam, Ninkovic, Slavisa, Hamad, Nada, McCaughan, Georgia, Kumar, Shaji, Spencer, Andrew and Quach, Hang (2024). Integrating Chromosomal 1 Abnormalities into the Definition of High-Risk Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-207609 |
|
2024 Conference Publication Impact of Socioeconomic Status on Utilisation of ASCT and Overall Survival in Multiple Myeloma: A Report from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (ANZ MRDR)Gration, Betty, Wellard, Cameron, Moore, Elizabeth, Mollee, Peter, Kerridge, Ian H., Spencer, Andrew, Shetty, Anita, Baker, Bart, Forsyth, Cecily, Heenan, Jessica, McQuilten, Zoe K, Wood, Erica M. and McCaughan, Georgia (2024). Impact of Socioeconomic Status on Utilisation of ASCT and Overall Survival in Multiple Myeloma: A Report from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (ANZ MRDR). 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-199451 |
|
2024 Conference Publication Plasma Cell Enumeration By Manual and Automated Methods to Establish a Standard Pictorial ReferenceMurali, Aarya, Tobin, Joshua W.D. and Mollee, Peter (2024). Plasma Cell Enumeration By Manual and Automated Methods to Establish a Standard Pictorial Reference. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-204199 |
|
2024 Conference Publication Development of a self-reported frailty index - The SELFISia, Aaron Din How, Mollee, Peter, Berry, Robyn, Ladwa, Rahul, Ling, Victoria, Fletcher, James, Gordon, Emily, Walpole, Euan, Hanjani, Leila Shafiee, Reid, Natasha, Simonsen, Camilla and Hubbard, Ruth Eleanor (2024). Development of a self-reported frailty index - The SELFI. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13-15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.14117 |
|
2024 Conference Publication Comparing the outcomes of frail acute myeloid leukaemia patients undergoing systemic therapy to their fitter counterpartsSia, Aaron, Chopra, Sakshi, Ling, Victoria, Hubbard, Ruth Eleanor, Mollee, Peter, Gordon, Emily and Hanjani, Leila Shafiee (2024). Comparing the outcomes of frail acute myeloid leukaemia patients undergoing systemic therapy to their fitter counterparts. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13–15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.14117 |
|
2024 Conference Publication An individualised bone-targeted exercise intervention for people with multiple myeloma: study protocol of the MyeEx-impact randomised controlled trialChong, Jamie, Nicol, Jennifer, Beck, Belinda, Kay, Shelley, Hart, Nicolas, Carter, Daniel, Woodrow, Carmel, Cunningham, Brent, Farley, Morgan, Boytar, Alexander, Baguley, Brenton, Rose, Grace, Mollee, Peter and Skinner, Tina (2024). An individualised bone-targeted exercise intervention for people with multiple myeloma: study protocol of the MyeEx-impact randomised controlled trial. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13–15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2023 Conference Publication Serial 18F-Florbetaben Positron Emission Tomography and Cardiac Magnetic Resonance Imaging in the Evaluation of Systemic Light Chain Cardiac Amyloidosis Enhances Diagnostic and Response Assessment AccuracyRanjit Anderson, Nirija, Law, W. Phillip, Dong, Xin, Ng, Arnold C.T and Mollee, Peter (2023). Serial 18F-Florbetaben Positron Emission Tomography and Cardiac Magnetic Resonance Imaging in the Evaluation of Systemic Light Chain Cardiac Amyloidosis Enhances Diagnostic and Response Assessment Accuracy. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-186377 |
|
2023 Conference Publication Planned Interim Safety Analysis of the Phase 3 Randomized Trial of Selinexor and Lenalidomide Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Patients with Newly Diagnosed Multiple Myeloma (ALLG MM23; Sealand)Quach, Hang, Lasica, Masa, Low, Michael, Mollee, Peter, Lai, Hock Choong, Wong Doo, Nicole, Hocking, Jay, Campbell, Philip, Murphy, Nicholas E., Sidiqi, M. Hasib, Routledge, David, Heenan, Jessica, Horvath, Noemi, Eek, Richard, Renwick, William E. P., Lenton, Douglas Stuart, Child, Lauren J, McCaughan, Georgia, Butcher, Belinda E, Mazumdar, Deepmala and Kalff, Anna (2023). Planned Interim Safety Analysis of the Phase 3 Randomized Trial of Selinexor and Lenalidomide Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Patients with Newly Diagnosed Multiple Myeloma (ALLG MM23; Sealand). 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-185169 |
|
2023 Conference Publication Impact of 1q21 Gain and Amplification on Daratumumab-Treated Multiple Myeloma Patients: Real-World Data from the Australia-New Zealand and Asia-Pacific Myeloma and Related Diseases RegistriesLim, Kenneth J. C., Wellard, Cameron, Moore, Elizabeth, Ninkovic, Slavisa, Chng, Wee-Joo, Spencer, Andrew, Mollee, Peter, Hocking, Jay, Ho, Phoebe Joy, Janowski, Wojt, Kim, Kihyun, Dun, Karen, McQuilten, Zoe K., Chen, Fiona and Quach, Hang (2023). Impact of 1q21 Gain and Amplification on Daratumumab-Treated Multiple Myeloma Patients: Real-World Data from the Australia-New Zealand and Asia-Pacific Myeloma and Related Diseases Registries. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-173896 |
